Correlation Between Amicus Therapeutics and Merck

Can any of the company-specific risk be diversified away by investing in both Amicus Therapeutics and Merck at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amicus Therapeutics and Merck into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Amicus Therapeutics and Merck Company, you can compare the effects of market volatilities on Amicus Therapeutics and Merck and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amicus Therapeutics with a short position of Merck. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amicus Therapeutics and Merck.

Diversification Opportunities for Amicus Therapeutics and Merck

0.04

Correlation Coefficient

Amicus Therapeutics  Merck

Significant diversification

The 3 months correlation between Amicus and Merck is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Amicus Therapeutics and Merck Company in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merck Company and Amicus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amicus Therapeutics are associated (or correlated) with Merck. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merck Company has no effect on the direction of Amicus Therapeutics i.e., Amicus Therapeutics and Merck go up and down completely randomly.

Pair Corralation between Amicus Therapeutics and Merck

Given the investment horizon of 90 days Amicus Therapeutics is expected to under-perform the Merck. But the stock apears to be less risky and, when comparing its historical volatility, Amicus Therapeutics is 1.04 times less risky than Merck. The stock trades about -0.11 of its potential returns per unit of risk. The Merck Company is currently generating about -0.1 of returns per unit of risk over similar time horizon. If you would invest  9,885  in Merck Company on December 27, 2024 and sell it today you would lose (1,125) from holding Merck Company or give up 11.38% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	98.36%
Values	Daily Returns

Amicus Therapeutics  vs.  Merck Company

Amicus Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Amicus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's essential indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Merck Company

Risk-Adjusted Performance

Very Weak

Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest abnormal performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Pair Trading with Amicus Therapeutics and Merck

The main advantage of trading using opposite Amicus Therapeutics and Merck positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amicus Therapeutics position performs unexpectedly, Merck can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merck will offset losses from the drop in Merck's long position.

The idea behind Amicus Therapeutics and Merck Company pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.